[Prostate cancer gene therapy]

Yasutomo Nasu1, Hiromi Kumon

  • 1Department of Urology, Okayama University Graduate School of Medicine and Dentistry.

Insights

Gene therapy shows promise for prostate cancer treatment, with ongoing clinical trials exploring various therapeutic genes. Further advancements in technology and research are paving the way for its wider clinical application.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Context:

  • Advances in genetic engineering, tumor biology, and immunology have positioned gene therapy as a viable treatment for various cancers.
  • Prostate cancer, a significant health concern, is being targeted by innovative gene therapy approaches.

Purpose:

  • To summarize the general concepts and current progress of gene therapy specifically for prostate cancer.
  • To highlight the potential of gene therapy as a future clinical option for prostate cancer patients.

Summary:

  • Several clinical trials are actively investigating prostate cancer gene therapy, utilizing therapeutic genes such as suicide genes, immunomodulatory genes, tumor suppressor genes, and anti-oncogenes.
  • While still in early stages and requiring technological breakthroughs, current trial data suggest significant potential for gene therapy in treating prostate cancer.
  • Progress in both fundamental research and gene therapy technology is crucial for the future widespread adoption of this treatment modality.

Impact:

  • Gene therapy offers a promising new avenue for prostate cancer treatment, potentially improving patient outcomes.
  • Continued research and technological development are expected to make prostate cancer gene therapy a standard clinical practice in the future.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...